Cargando…

Index hospital cost of adverse events following thoracic surgery: a systematic review of economic literature

OBJECTIVES: Adverse events (AEs) following thoracic surgery place considerable strain on healthcare systems. A rigorous evaluation of the economic impact of thoracic surgical AEs remains lacking and is required to understand the value of money of formal quality improvement initiatives. Our objective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jones, Daniel, Kumar, Srishti, Anstee, Caitlin, Gingrich, Molly, Simone, Alexander, Ahmadzai, Zubair, Thavorn, Kednapa, Seely, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Health Economics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546169/ https://www.ncbi.nlm.nih.gov/pubmed/37770272 http://dx.doi.org/10.1136/bmjopen-2022-069382

Ejemplares similares

Multicentre positive deviance to reduce adverse events and length of stay after pulmonary resection
por: Seely, Andrew J E, et al.
Publicado: (2023)

Harmonization of adverse events monitoring following thoracic surgery: Pursuit of a common language and methodology
por: Sigler, Gregory, et al.
Publicado: (2021)

Economic impact of potentially inappropriate prescribing and related adverse events in older people: a cost-utility analysis using Markov models
por: Moriarty, Frank, et al.
Publicado: (2019)

Stakeholder engagement in economic evaluation: Protocol for using the nominal group technique to elicit patient, healthcare provider, and health system stakeholder input in the development of an early economic evaluation model of chimeric antigen receptor T-cell therapy
por: Wilson, Mackenzie, et al.
Publicado: (2021)

Cost–utility analysis of apixaban compared with usual care for primary thromboprophylaxis in ambulatory patients with cancer
por: Kimpton, Miriam, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of Smoking Cessation Interventions in the United Kingdom Accounting for Major Neuropsychiatric Adverse Events
por: Keeney, Edna, et al.
Publicado: (2021)

MA12.05 The Impact of the COVID-19 Pandemic on Post-Operative Outcomes of Thoracic Cancer Surgery in Canada
por: Huynh, C., et al.
Publicado: (2021)

Economic impact of delirium in Australia: a cost of illness study
por: Pezzullo, Lynne, et al.
Publicado: (2019)

Comparative economic study of the use of corifollitropin alfa and daily rFSH for controlled ovarian stimulation in older patients: Cost-minimization analysis based on the PURSUE study
por: Barrenetxea, Gorka, et al.
Publicado: (2018)

The process and costs of publishing medical journals in Sri Lanka: an economic evaluation
por: Ranasinghe, P, et al.
Publicado: (2011)

Economic burden of schizophrenia in Italy: a probabilistic cost of illness analysis
por: Marcellusi, Andrea, et al.
Publicado: (2018)

Audit feedback interventions to address high-risk prescriptions in long-term care homes: a costing study and return on investment analysis
por: Thavorn, Kednapa, et al.
Publicado: (2021)

Incidence, causes, and consequences of preventable adverse drug events: protocol for an overview of reviews
por: Hutton, Brian, et al.
Publicado: (2016)

Economic evaluation of a novel community-based diabetes care model in rural Mexico: a cost and cost-effectiveness study
por: Duan, Kevin I, et al.
Publicado: (2021)

Are complementary therapies and integrative care cost-effective? A systematic review of economic evaluations
por: Herman, Patricia M, et al.
Publicado: (2012)

Economic burden of cancers in Taiwan: a direct and indirect cost estimate for 2007–2017
por: Huang, Shao-Yi, et al.
Publicado: (2020)

Costs of Next-Generation Sequencing Assays in Non-Small Cell Lung Cancer: A Micro-Costing Study
por: Kumar, Srishti, et al.
Publicado: (2022)

Are sequential compression devices routinely necessary following enhanced recovery after thoracic surgery?
por: Abdul, Sami Aftab, et al.
Publicado: (2022)

COVID-19 Pandemic: Did Strict Mobility Restrictions Save Lives and Healthcare Costs in Maharashtra, India?
por: Ambade, Preshit Nemdas, et al.
Publicado: (2023)

Distributional consequences of including survivor costs in economic evaluations
por: Kellerborg, Klas, et al.
Publicado: (2021)

Cost-effectiveness of providing university students with a mindfulness-based intervention to reduce psychological distress: economic evaluation of a pragmatic randomised controlled trial
por: Wagner, Adam P, et al.
Publicado: (2023)

Development of an economic model to assess the cost-effectiveness of hawthorn extract as an adjunct treatment for heart failure in Australia
por: Ford, Emily, et al.
Publicado: (2012)

Cost-effectiveness of new MDR-TB regimens: study protocol for the TB-PRACTECAL economic evaluation substudy
por: Sweeney, Sedona, et al.
Publicado: (2020)

Emergency Department disposition decisions and associated mortality and costs in ICU patients with suspected infection
por: Fernando, Shannon M., et al.
Publicado: (2018)

Cost-effectiveness of total hip arthroplasty versus resurfacing arthroplasty: economic evaluation alongside a clinical trial
por: Edlin, Richard, et al.
Publicado: (2012)

Economic burden of multidrug-resistant bacteria in nursing homes in Germany: a cost analysis based on empirical data
por: Huebner, Claudia, et al.
Publicado: (2016)

Economic costs of automated and continuous ambulatory peritoneal dialysis in Taiwan: a combined survey and retrospective cohort analysis
por: Tang, Chao-Hsiun, et al.
Publicado: (2017)

The cost‐effectiveness of progesterone in preventing miscarriages in women with early pregnancy bleeding: an economic evaluation based on the PRISM trial
por: Okeke Ogwulu, CB, et al.
Publicado: (2020)

Healthcare costs of adverse drug reactions and potentially inappropriate prescribing in older adults: a population-based study
por: Robinson, Eirin Guldsten, et al.
Publicado: (2022)

Cost comparison of orthopaedic fracture pathways using discrete event simulation in a Glasgow hospital
por: Anderson, Gillian H, et al.
Publicado: (2017)

The economic benefit of hip replacement: a 5-year follow-up of costs and outcomes in the Exeter Primary Outcomes Study
por: Fordham, Richard, et al.
Publicado: (2012)

Economic burden of managing oral cancer patients in Sri Lanka: a cross-sectional hospital -based costing study
por: Amarasinghe, Hemantha, et al.
Publicado: (2019)

When has service provision for transient ischaemic attack improved enough? A discrete event simulation economic modelling study
por: Barton, Pelham, et al.
Publicado: (2017)

The cost-effectiveness of initiating ranibizumab therapy in eyes with neovascular AMD with good vision: an economic model using real-world outcomes
por: Butt, Thomas, et al.
Publicado: (2015)

Health economics of targeted intraoperative radiotherapy (TARGIT-IORT) for early breast cancer: a cost-effectiveness analysis in the United Kingdom
por: Vaidya, Anil, et al.
Publicado: (2017)

What are the cost-savings and health benefits of improving detection and management for six high cardiovascular risk conditions in England? An economic evaluation
por: Thomas, Chloe, et al.
Publicado: (2020)

Is telehealthcare for heart failure patients cost-effective? An economic evaluation alongside the Danish TeleCare North heart failure trial
por: Vestergaard, Anne Sig, et al.
Publicado: (2020)

Cost-effectiveness of prehabilitation prior to elective surgery compared to usual preoperative care: protocol for a systematic review of economic evaluations
por: Rombey, Tanja, et al.
Publicado: (2020)

Cerebrospinal fluid leakage costs after craniotomy and health economic assessment of incidence reduction from a hospital perspective in the Netherlands
por: van Lieshout, Chris, et al.
Publicado: (2021)

Economic evaluation of advanced practice physiotherapy models of care: a systematic review with meta-analyses
por: Lafrance, Simon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dlsrpte11pnn41i60s7f73qfdr